Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities

BACKGROUND: Comorbidities in patients with chronic obstructive pulmonary disease (COPD) are associated with increased medical costs and risk of exacerbations. This study compared COPD-related medical costs and exacerbations in high-cost, high-comorbidity patients with COPD receiving initial maintena...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Chron Obstruct Pulmon Dis
Auteurs principaux: Kalhan, Ravi, Slade, David, Ray, Riju, Moretz, Chad, Germain, Guillaume, Laliberté, François, Shen, Qin, Duh, Mei Sheng, MacKnight, Sean Dale, Hahn, Beth
Format: Artigo
Langue:Inglês
Publié: Dove 2021
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8075186/
https://ncbi.nlm.nih.gov/pubmed/33911860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S298032
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires